Obesity and mortality: Summary of best evidence with explanations for the obesity paradox

Heart and Metabolism

Volumn , Issue 48, 2010, Pages 11-13

  Logue, Jennifer ^a   Sattar, Naveed ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cardiovascular disease; Death; Mortality; Obesity; Obesity paradox

Indexed keywords

BARIATRIC SURGERY; BODY MASS; CACHEXIA; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HEART FAILURE; HUMAN; IMMUNE SYSTEM; META ANALYSIS (TOPIC); MORTALITY; OBESITY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SURVIVAL RATE; WEIGHT REDUCTION;

EID: 78751481426     PISSN: 15660338     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083-1096.
2. Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359:2105-2120.
3. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008;156:13-22.
4. Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666-678. (Pubitemid 44223694)
5. Escalante A, Haas RW, del Rincón I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med. 2005;165:1624-1629. (Pubitemid 41124157)
6. Mullen JT, Moorman DW, Davenport DL. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg. 2009;250:166-172.
7. Berry C, Clark AL. Catabolism in chronic heart failure. Eur Heart J. 2000;21:521-532.
8. Fearon KC, Voss AC, Hustead DS. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006;83:1345-1350.
9. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998;394:897-901. (Pubitemid 28410912)
10. Logue J, Thompson L, Romanes F, Wilson DC, Thompson J, Sattar N. Management of obesity: summary of SIGN guideline. BMJ. 2010;340:c154.
11. USFood and Drug Administration. Follow-Upto theNovember 2009 Early Communication about an Ongoing Safety Review of Sibutramine, Marketed as Meridia. Posted on 21-1-2010. Available on: http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/ucm198206.htm.
12. Ostergaard JN, Gronbaek M, Schnohr P, Sorensen TI, Heitmann BL. Combined effects of weight loss and physical activity on all-cause mortality of overweight men and women. Int J Obes (Lond). 2010;34:760-769.
13. Mikkelsen KL, Heitmann BL, Keiding N, Sorensen TI. Independent effects of stable and changing body weight on total mortality. Epidemiology. 1999;10:671-678. (Pubitemid 29494046)
14. Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-752.
15. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753-761. (Pubitemid 47295642)